Skip to content
View LilyYNY's full-sized avatar
💭
good luck
💭
good luck
  • Soochow University
  • Suzhou, China

Block or report LilyYNY

Block user

Prevent this user from interacting with your repositories and sending you notifications. Learn more about blocking users.

You must be logged in to block users.

Maximum 250 characters. Please don’t include any personal information such as legal names or email addresses. Markdown is supported. This note will only be visible to you.
Report abuse

Contact GitHub support about this user’s behavior. Learn more about reporting abuse.

Report abuse
LilyYNY/README.md

Miao Yang

M.S. candidate in Medical Systems Biology at Soochow University.

My research focuses on interpretable machine learning, missense mutation interpretation, structural bioinformatics, molecular dynamics, network medicine, and cancer omics.

Research Interests

  • Interpretable machine learning for missense mutation interpretation
  • Structural bioinformatics and molecular dynamics of disease-associated mutations
  • Network medicine and AI-driven drug repositioning
  • Single-cell transcriptomics in cancer biology

Featured Projects

Publications

  • Yang M#, Wang J#, Zhou Z, Li W, Verkhivker G, Xiao F, Hu G. Machine Learning and Structural Dynamics-Based Approach to Reveal Molecular Mechanism of PTEN Missense Mutations Shared by Cancer and Autism Spectrum Disorder. Journal of Chemical Information and Modeling, 2025, 65(8): 4173-4188.

  • Wang J#, Yang M#, Zong C, Li Y, Verkhivker G, Xiao F, Hu G. protPheMut: An Interpretable Machine Learning Tool for Classification of Cancer and Neurodevelopmental Disorders in Human Missense Mutations. Journal of Chemical Information and Modeling, 2025, 65(15): 8375-8384.

Equal contribution.

Software

Skills

  • Programming: Python, R, Bash/Shell scripting, SQL; experienced in large-scale biological data processing, statistical analysis, visualization, and reproducible computational workflows.
  • Machine Learning: scikit-learn, XGBoost, LightGBM, CatBoost, SHAP, Optuna; feature engineering, feature selection, cross-validation, ensemble/stacking models, model interpretation, ROC/PR/calibration analysis.
  • Bioinformatics: Mutation data curation, sequence conservation and coevolution analysis, GO/KEGG enrichment, ssGSEA/module scoring, consensus clustering, survival analysis, tumor mutation analysis, single-cell transcriptomic analysis; familiar with limma, sva/ComBat, ConsensusClusterPlus, clusterProfiler, GSVA, maftools, Seurat, and AUCell.
  • Structural Bioinformatics & Molecular Dynamics: AlphaFold, PyMOL, GROMACS, MDAnalysis, MD-TASK, FoldX, fpocket; RMSD/RMSF, DCCM, dynamic residue networks, shortest-pathway/allosteric communication analysis, protein pocket analysis, and mutation mechanism interpretation.
  • Network Biology: STRING and physical PPI networks, residue interaction networks, network topology analysis, Louvain/Walktrap community detection, disease module identification, and network-based drug repositioning.

Popular repositories Loading

  1. subnetDR subnetDR Public

    subnetDR is an R/Python workflow for subtype-specific network module identification and drug repositioning.

    R

  2. LilyYNY LilyYNY Public

    Research portfolio of Miao Yang

  3. pten-cancer-asd-mutational-mechanisms pten-cancer-asd-mutational-mechanisms Public

    Machine learning and structural dynamics workflows for interpreting PTEN missense mutations shared by cancer and ASD.

    R

  4. protphemut-interpretable-mutation-analysis protphemut-interpretable-mutation-analysis Public

    Interpretable machine learning analyses for classifying cancer and neurodevelopmental disorder missense mutations.

    Python

  5. pathway-allosteric-mutations-md pathway-allosteric-mutations-md Public

    protPheMut-based screening and molecular dynamics validation of distal allosteric mutations in RAS/MAPK/PI3K pathway proteins.

  6. luad-network-drug-repositioning luad-network-drug-repositioning Public

    Network medicine and AI-driven drug repositioning workflows for lung adenocarcinoma proteomics.